Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

AIM: We aimed to compare cardiovascular outcomes of patients with type 2 diabetes (T2D) who initiated GLP-1 receptor agonists (GLP-1RA) or basal insulin (BI) under routine care. METHODS: We accessed the administrative claims database of the Veneto Region (Italy) to identify new users of GLP-1RA or B...

Descripción completa

Detalles Bibliográficos
Autores principales: Longato, Enrico, Di Camillo, Barbara, Sparacino, Giovanni, Tramontan, Lara, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590792/
https://www.ncbi.nlm.nih.gov/pubmed/34774054
http://dx.doi.org/10.1186/s12933-021-01414-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590792/
https://www.ncbi.nlm.nih.gov/pubmed/34774054
http://dx.doi.org/10.1186/s12933-021-01414-3

Ejemplares similares